• Rucaparib

Rucaparib (trade name Rubraca) is a PARP inhibitor targeting the DNA repair enzyme poly-ADP ribose polymerase-1 (PARP-1) for the treatemnt of advanced ovarian cancer. Rucaparib has been approved by the U.S Food and Drug Administration on December 19, 2016.

Specifications

Product Name:                  Rucaparib

Synonyms:                         AG 014699

CAS Number:                     283173-50-2

Molecular Weight:            323.3691

Molecular Formula:          C19H18FN3O

Purity (HPLC):                     ≥99%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               CNCc1ccc(cc1)c1[nH]c2c3c1CCNC(=O)c3cc(c2)F

Write a review

Note: HTML is not translated!
    Bad           Good

Rucaparib

  • $400.00

  • Ex Tax: $400.00

Available Options